differentiated antibiotics

Cempra Reports Fourth Quarter and Full Year 2014 Financial Results and Provides Corporate Update

CHAPEL HILL, N.C., Feb. 25, 2015 -- Cempra, Inc. (Nasdaq:CEMP), a clinical-stage pharmaceutical company focused on developing antibiotics to meet critical medical needs in the treatment of bacterial infectious diseases, today reported financial results for the quarter and year ended December 31, 2014 and provided an update on recent corporate developments. The company will host a webcast and conference call today at 4:30 p.m. EST.

 

Cempra to Report Fourth Quarter and Full Year 2014 Financial Results

CHAPEL HILL, N.C., Feb. 17, 2015 -- Cempra, Inc. (Nasdaq:CEMP), a clinical-stage pharmaceutical company focused on developing antibiotics to meet critical medical needs in the treatment of bacterial infectious diseases, today announced that it will report fourth quarter and full year 2014 financial results after the close of U.S. financial markets on February 25, 2015. Cempra management will host a webcast and conference call at 4:30 p.m. EST that day to discuss the financial results and provide a corporate update.